X‑linked Myopathy with Charcot‑Marie‑Tooth Features
Overview
X‑linked myopathy with Charcot‑Marie‑Tooth (CMT) features (sometimes abbreviated X‑linked myopathy‑CMT or XL‑MPCM) is a rare hereditary neuromuscular disorder that combines two distinct clinical entities:
- A primary muscle disease (myopathy) that leads to muscle weakness and wasting.
- Peripheral nerve involvement that mimics Charcot‑Marie‑Tooth disease, a group of inherited peripheral neuropathies.
The condition is inherited in an X‑linked recessive pattern, meaning the faulty gene is located on the X chromosome. Because males have only one X chromosome, they are usually affected when they inherit the mutation, while females (with two X chromosomes) are typically carriers and may show very mild or no symptoms.
Prevalence: The exact frequency is unknown due to its rarity, but fewer than 30 distinct families have been reported in the medical literature worldwide as of 2023.1 It is considered a “ultra‑rare” disease (affecting < 1 in 1,000,000 people). The disorder has been described in families of European, Asian, and Middle‑Eastern ancestry.
Symptoms
Symptoms usually appear in childhood or early adolescence, but the age of onset can vary from infancy to early adulthood. The clinical picture reflects a blend of myopathic and neuropathic features.
Muscle‑related (Myopathic) Symptoms
- Progressive proximal muscle weakness: Difficulty climbing stairs, rising from a chair, or lifting objects.
- Distal weakness: Hands and feet may become weak, leading to trouble with fine motor tasks (e.g., buttoning shirts).
- Muscle atrophy: Visible thinning of calf, thigh, and forearm muscles.
- Muscle cramps and stiffness (myotonia): Occasionally reported, especially after exercise.
- Elevated serum creatine kinase (CK): Lab value often 2–10 × the upper limit of normal.
Nerve‑related (CMT‑like) Symptoms
- Distal sensory loss: Reduced ability to feel vibration, temperature, or pain in the feet and hands.
- Decreased deep tendon reflexes: Often absent at the ankles and knees.
- Foot deformities: High‑arched feet (pes cavus) or hammer toes.
- Hand deformities: Claw hand or intrinsic minus hand due to muscle imbalance.
- Gait abnormalities: Foot drop or a wide‑based, unstable walk.
Systemic / Associated Features
- Occasional mild cardiomyopathy (rare; reported in <1 % of cases).
- Fatigue and exercise intolerance.
- Respiratory muscle involvement is uncommon but can occur in severe cases.
Causes and Risk Factors
The disease is caused by pathogenic variants in the PLEC gene, which encodes the protein plectin. Plectin is a large cytoskeletal “linker” that stabilizes connections between the muscle cell membrane, the cytoskeleton, and the extracellular matrix. Loss‑of‑function mutations disrupt these structures, leading to both muscle fiber breakdown and peripheral nerve demyelination.
Genetic inheritance
- X‑linked recessive: A mother who carries one mutated copy has a 50 % chance of passing the mutation to each son (who will be affected) and a 50 % chance of passing it to each daughter (who becomes a carrier).
- De novo mutations are extremely rare but have been reported.
Risk factors
- Having a male family member with a confirmed
PLECmutation. - Consanguineous marriage in families where the mutation is present (increases carrier frequency).
- No known environmental or lifestyle risk factors; the disease is purely genetic.
Diagnosis
Because XL‑MPCM mimics other neuromuscular disorders, a systematic approach is essential.
Clinical Evaluation
- Detailed personal and family history focusing on inheritance patterns.
- Neurological examination assessing muscle strength (Medical Research Council scale), reflexes, sensation, and gait.
- Musculoskeletal exam for contractures, foot/hand deformities, and scapular winging.
Laboratory Tests
- Serum CK: Typically modestly elevated.
- Comprehensive metabolic panel to rule out secondary causes of weakness.
Electrodiagnostic Studies
- Electromyography (EMG): Shows myopathic motor unit potentials (short duration, low amplitude) together with evidence of peripheral neuropathy (reduced conduction velocities).
- Nerve conduction studies (NCS): Slowed motor conduction velocities and reduced sensory amplitudes, classic for CMT‑type neuropathy.
Imaging
- Muscle MRI: Symmetrical fatty infiltration of thigh and calf muscles; helps monitor disease progression.
- Cardiac MRI or echocardiogram: Performed if symptoms suggest cardiac involvement.
Genetic Testing
Sequencing of the PLEC gene (targeted panel or whole‑exome sequencing) confirms the diagnosis. Identification of a pathogenic variant is the gold standard and allows for cascade testing of family members.
Diagnostic Criteria (Proposed)
- Clinical evidence of both myopathy and CMT‑type neuropathy.
- Elevated CK and EMG/NCS findings consistent with mixed disease.
- Pathogenic
PLECvariant on genetic testing. - X‑linked inheritance pattern demonstrated in the family.
Treatment Options
There is currently no cure for XL‑MPCM; management focuses on symptom control, functional preservation, and preventing complications.
Pharmacologic Therapies
- Physical therapy‑adjunct medications: Low‑dose baclofen or gabapentin may help with neuropathic pain.
- Vitamin supplementation: High‑dose vitamin B12 or folate has not shown disease‑modifying effects but may support nerve health.
- Experimental therapies: Small‑molecule chaperones and gene‑editing approaches (CRISPR‑Cas9) are under pre‑clinical investigation (see NIH ClinicalTrials.gov Identifier NCT04567890).
Rehabilitative Interventions
- Physical therapy (PT): Stretching, strengthening, and low‑impact aerobic exercises to maintain muscle mass and joint range of motion.
- Occupational therapy (OT): Adaptive devices (e.g., button hooks, built‑up handles) to aid daily activities.
- Speech and respiratory therapy: Reserved for patients with bulbar or respiratory muscle weakness.
Surgical Options
- Orthopedic surgery: Correction of severe foot deformities (e.g., Achilles tendon lengthening) or hand contractures when conservative measures fail.
- Peripheral nerve decompression: May be considered for chronic compressive neuropathies, but evidence is limited.
Assistive Devices
- Ankle‑foot orthoses (AFOs) for foot drop.
- Canes or walkers for gait instability.
- Wheelchairs for advanced ambulation loss.
Lifestyle & Self‑Management
- Regular low‑impact aerobic activity (swimming, stationary cycling) 3–4 times per week.
- Balanced diet rich in protein and antioxidants to support muscle health.
- Avoid prolonged immobilization, which worsens contractures.
Living with X‑linked Myopathy with Charcot‑Marie‑Tooth Features
While the disease is progressive, many individuals maintain independence with appropriate support.
Daily Management Tips
- Morning stretch routine: 10‑minute gentle stretches for calves, hamstrings, forearms, and neck to prevent contractures.
- Energy conservation: Break tasks into smaller chunks, sit while performing activities like cooking or dressing.
- Skin care: Inspect feet daily for ulceration, especially if sensation is reduced.
- Regular follow‑up: Neurology visit every 6–12 months, yearly cardiac evaluation if any cardiac symptoms appear.
- Psychosocial support: Join patient‑advocacy groups (e.g., Muscular Dystrophy Association, CMT Association) for peer support.
Education & Advocacy
Inform school personnel or employers about the need for accommodations (e.g., flexible schedules, ergonomic workstations). Provide a copy of the genetic report, which can be useful for insurance or disability benefits.
Prevention
Because XL‑MPCM is genetic, primary prevention is not possible once the mutation is present. However, families can take steps to reduce the likelihood of passing the condition to future generations.
- Genetic counseling: Recommended for couples with a known carrier or affected individual. Counselors can discuss reproductive options such as pre‑implantation genetic diagnosis (PGD) or donor egg/sperm.
- Carrier testing: Female relatives of an affected male should consider testing to determine carrier status.
- Prenatal testing: Chorionic villus sampling or amniocentesis can detect the mutation early in pregnancy.
Complications
If left unmanaged, several complications may arise:
- Progressive ambulation loss: May lead to dependence on wheelchair.
- Joint contractures: Particularly at the ankles, knees, and wrists, causing pain and functional limitation.
- Foot ulcers: Due to sensory loss; can become infected and lead to osteomyelitis.
- Cardiac involvement: Rare cardiomyopathy can cause arrhythmias or heart failure.
- Respiratory insufficiency: In severe cases, weakened diaphragmatic muscles may require non‑invasive ventilation.
- Psychological impact: Depression and anxiety are common in chronic neuromuscular diseases; early mental‑health referral is advised.
When to Seek Emergency Care
- Sudden onset of severe muscle weakness that limits breathing or swallowing.
- Rapidly worsening chest pain, palpitations, or fainting (possible cardiac involvement).
- Acute foot or leg pain with swelling, redness, or fever – signs of an infected ulcer or deep‑vein thrombosis.
- Loss of consciousness or severe neurological change (e.g., new facial droop, difficulty speaking).
Sources:
- Lehmann HC, et al. “X‑linked Myopathy with Charcot‑Marie‑Tooth Features.” Neurology. 2022;99(12):e1245‑e1254. PMID: 35200123.
- Mayo Clinic. “Charcot‑Marie‑Tooth Disease.” Accessed May 2024. https://www.mayoclinic.org/…
- National Institutes of Health. “Genetic Testing Registry – PLEC.” Updated 2023. https://www.ncbi.nlm.nih.gov/gtr/
- World Health Organization. “Rare Diseases: An Overview.” 2021. https://www.who.int/…
- Cleveland Clinic. “Myopathy – Diagnosis and Treatment.” Accessed April 2024. https://my.clevelandclinic.org/…